India Tariff Tracker: Trump's April 2026 Steel Tariffs Hit Exports, But Pharma Gets Relief

Welcome to India Tariff News and Tracker, your essential update on how U.S. trade policies are reshaping global flows with India. As of early April 2026, President Trump's aggressive tariff push continues to dominate headlines, with mixed economic signals and targeted measures hitting Indian exporters hard. One year after Trump's Liberation Day tariffs in April 2025, which imposed a baseline 10% on all imports and higher rates on dozens of countries including India, the results are uneven. National Today reports factory jobs down and inflation up, but Trump hailed the biggest drop in U.S. trade deficit history at 55%, crediting his policies as trading partners like India face pressure to open markets. The Economic Times quoted Trump directly on this win, though a February 2026 Supreme Court ruling struck down most emergency tariffs as unconstitutional, triggering over $150 billion in refunds via a complex U.S. Customs process that importers must claim entry-by-entry. India-specific impacts are intensifying. The Trump administration's April 2 proclamation ramps up Section 232 tariffs to 25% on steel, aluminum, and copper products effective April 6, based on total customs value—not just metal content—potentially hiking costs for Indian machinery and appliance exports, per PLP Networks' U.S. Logistics Update. For instance, a $1,000 washing machine with $200 in steel now faces a $250 tariff, up from prior calculations. Pharmaceuticals from India dodge the worst: a looming 100% tariff on patented drugs starts July 31 for big firms, but generics and biosimilars are exempt, with drawback options for FTA compliance. Supply chain ripples affect Indian freight too. Global air cargo rates to the U.S. surged 75% from South Asia amid U.S.-Iran tensions disrupting fuel, hitting India's export routes, as noted in logistics reports. Companies are rerouting via U.S. Foreign-Trade Zones to mitigate, according to NAFTZ feedback. Trump hints at 15% hikes before the 10% universal tariff expires July 24 under Trade Act Section 122. Indian firms with U.S. onshoring plans could snag pharma exemptions at 0-20%. Stay ahead of these shifts—India's exporters must watch refund deadlines and HTS codes like 9903.82.02 for compliance, per Customs guidance. Thanks for tuning in, listeners—subscribe now for weekly trackers. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.